200 related articles for article (PubMed ID: 36101495)
1. The signaling and selectivity of α-adrenoceptor agonists for the human α2A, α2B and α2C-adrenoceptors and comparison with human α1 and β-adrenoceptors.
Proudman RGW; Akinaga J; Baker JG
Pharmacol Res Perspect; 2022 Oct; 10(5):e01003. PubMed ID: 36101495
[TBL] [Abstract][Full Text] [Related]
2. The affinity and selectivity of α-adrenoceptor antagonists, antidepressants and antipsychotics for the human α2A, α2B, and α2C-adrenoceptors and comparison with human α1 and β-adrenoceptors.
Proudman RGW; Akinaga J; Baker JG
Pharmacol Res Perspect; 2022 Apr; 10(2):e00936. PubMed ID: 35224877
[TBL] [Abstract][Full Text] [Related]
3. Alpha2-adrenoceptor regulation of adenylyl cyclase in CHO cells: dependence on receptor density, receptor subtype and current activity of adenylyl cyclase.
Pohjanoksa K; Jansson CC; Luomala K; Marjamäki A; Savola JM; Scheinin M
Eur J Pharmacol; 1997 Sep; 335(1):53-63. PubMed ID: 9371546
[TBL] [Abstract][Full Text] [Related]
4. Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors.
Newman-Tancredi A; Nicolas JP; Audinot V; Gavaudan S; Verrièle L; Touzard M; Chaput C; Richard N; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):197-206. PubMed ID: 9750005
[TBL] [Abstract][Full Text] [Related]
5. The selectivity of α-adrenoceptor agonists for the human α1A, α1B, and α1D-adrenoceptors.
Proudman RGW; Baker JG
Pharmacol Res Perspect; 2021 Aug; 9(4):e00799. PubMed ID: 34355529
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of alpha 2-adrenoceptor-mediated responses in pig nasal mucosa.
Corboz MR; Varty LM; Rizzo CA; Mutter JC; Rivelli MA; Wan Y; Umland S; Qiu H; Jakway J; McCormick KD; Berlin M; Hey JA
Auton Autacoid Pharmacol; 2003 Aug; 23(4):208-19. PubMed ID: 15084187
[TBL] [Abstract][Full Text] [Related]
7. α
Sánchez-Soto M; Casadó-Anguera V; Yano H; Bender BJ; Cai NS; Moreno E; Canela EI; Cortés A; Meiler J; Casadó V; Ferré S
Mol Neurobiol; 2018 Nov; 55(11):8438-8454. PubMed ID: 29552726
[TBL] [Abstract][Full Text] [Related]
8. Analysis of ligand activation of alpha 2-adrenoceptor subtypes under conditions of equal G alpha protein stoichiometry.
Pauwels PJ; Wurch T; Tardif S; Finana F; Colpaert FC
Naunyn Schmiedebergs Arch Pharmacol; 2001 May; 363(5):526-36. PubMed ID: 11383713
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of postsynaptic alpha2-adrenoceptors of the dog mesenteric and rat femoral veins.
Paiva MQ; Morato M; Moura D; Guimarães S
Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):165-70. PubMed ID: 10494886
[TBL] [Abstract][Full Text] [Related]
10. Subtype-specific stimulation of [35S]GTPgammaS binding by recombinant alpha2-adrenoceptors.
Peltonen JM; Pihlavisto M; Scheinin M
Eur J Pharmacol; 1998 Aug; 355(2-3):275-9. PubMed ID: 9760042
[TBL] [Abstract][Full Text] [Related]
11. Alpha2-adrenoceptor agonists stimulate high-affinity GTPase activity in a receptor subtype-selective manner.
Jansson CC; Pohjanoksa K; Lang J; Wurster S; Savola JM; Scheinin M
Eur J Pharmacol; 1999 Jun; 374(1):137-46. PubMed ID: 10422650
[TBL] [Abstract][Full Text] [Related]
12. Tasipimidine-the pharmacological profile of a novel orally active selective α
Lehtimäki J; Jalava N; Unkila K; Aspegren J; Haapalinna A; Pesonen U
Eur J Pharmacol; 2022 May; 923():174949. PubMed ID: 35405115
[TBL] [Abstract][Full Text] [Related]
13. A study of presynaptic alpha2-autoreceptors in alpha2A/D-, alpha2B- and alpha2C-adrenoceptor-deficient mice.
Trendelenburg AU; Klebroff W; Hein L; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 2001 Aug; 364(2):117-30. PubMed ID: 11534851
[TBL] [Abstract][Full Text] [Related]
14. [3H]RS79948-197 binding to human, rat, guinea pig and pig alpha2A-, alpha2B- and alpha2C-adrenoceptors. Comparison with MK912, RX821002, rauwolscine and yohimbine.
Uhlén S; Dambrova M; Näsman J; Schiöth HB; Gu Y; Wikberg-Matsson A; Wikberg JE
Eur J Pharmacol; 1998 Feb; 343(1):93-101. PubMed ID: 9551719
[TBL] [Abstract][Full Text] [Related]
15. Yohimbine dimers exhibiting selectivity for the human alpha 2C-adrenoceptor subtype.
Lalchandani SG; Lei L; Zheng W; Suni MM; Moore BM; Liggett SB; Miller DD; Feller DR
J Pharmacol Exp Ther; 2002 Dec; 303(3):979-84. PubMed ID: 12438517
[TBL] [Abstract][Full Text] [Related]
16. Subtypes of functional alpha1- and alpha2-adrenoceptors.
Docherty JR
Eur J Pharmacol; 1998 Nov; 361(1):1-15. PubMed ID: 9851536
[TBL] [Abstract][Full Text] [Related]
17. The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptors.
Baker JG
Br J Pharmacol; 2010 Jul; 160(5):1048-61. PubMed ID: 20590599
[TBL] [Abstract][Full Text] [Related]
18. The differential
López-Córdoba G; Martínez-Lorenzana G; Lozano-Cuenca J; Condés-Lara M; González-Hernández A
Front Pharmacol; 2022; 13():1023611. PubMed ID: 36506544
[TBL] [Abstract][Full Text] [Related]
19. Activation of alpha 2B-adrenoceptors mediates the cardiovascular effects of etomidate.
Paris A; Philipp M; Tonner PH; Steinfath M; Lohse M; Scholz J; Hein L
Anesthesiology; 2003 Oct; 99(4):889-95. PubMed ID: 14508322
[TBL] [Abstract][Full Text] [Related]
20. Expression and function of alpha-adrenoceptors in zebrafish: drug effects, mRNA and receptor distributions.
Ruuskanen JO; Peitsaro N; Kaslin JV; Panula P; Scheinin M
J Neurochem; 2005 Sep; 94(6):1559-69. PubMed ID: 16000146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
